What is NDC 0591-0398?

0591-0398 is the product NDC for Diclofenac Sodium and Misoprostol, Diclofenac sodium 75 mg/1; Misoprostol 200 ug/1 tablet, delayed release, listed with the FDA by Actavis Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Diclofenac sodium, Misoprostol.

Actavis Pharma, Inc., NDC labeler code 0591. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Diclofenac Sodium and Misoprostol?

10 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Diclofenac Sodium and Misoprostol NDC 0591-0398

NDC codes

FDA NDC Directory

Product NDC (as listed)0591-0398Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00591-0398Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0591-0398-60	0059103986000591039860	60 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0591-0398-60)Marketed from Nov 1, 2012

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Diclofenac Sodium and Misoprostol
Generic name (nonproprietary): diclofenac sodium and misoprostol
Active ingredients: Diclofenac sodium — 75 mg/1Misoprostol — 200 ug/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Actavis Pharma, Inc.NDC labeler code 0591
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201089
Marketing start: Nov 1, 2012
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Decreased Prostaglandin Production (Physiologic effect)Synthetic (Chemical structure)
Identifiers: Product ID 0591-0398_74d02999-d777-4cda-94b9-7b2420a8258cSPL ID 74d02999-d777-4cda-94b9-7b2420a8258cSPL set ID df8b8660-0c24-4848-8bea-c1b935090c66RxCUI 857706, 1359105UNII QTG126297Q, 0E43V0BB57UPC 0305910397609, 0305910398606
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug; Prostaglandin E1 Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400591039860 followed by a unit qualifier and the quantity

Package 00591-0398-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in adult patients at high risk of developing NSAID-induced gastric and duodenal ulcers and their complications. For a list of factors that may increase the risk of NSAID-induced gastric and duodenal ulcers and their complications [see Warnings and Precautions (5.3) ]. Diclofenac sodium and misoprostol delayed-release tablets are a combination of diclofenac sodium, a non-steroidal anti-inflammatory drug, and misoprostol, a prostaglandin-1 (PGE1) analog, indicated for the treatment of signs and symptoms of osteoarthritis or rheumatoid arthrit…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0591-0398

What is NDC 0591-0398?: 0591-0398 is the product NDC for Diclofenac Sodium and Misoprostol, Diclofenac sodium 75 mg/1; Misoprostol 200 ug/1 tablet, delayed release, listed with the FDA by Actavis Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Diclofenac Sodium and Misoprostol.
What is the active ingredient?: Diclofenac sodium, Misoprostol.
Who is the labeler?: Actavis Pharma, Inc., NDC labeler code 0591. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Diclofenac Sodium and Misoprostol?: 10 other product NDCs are listed under this name. See all Diclofenac Sodium and Misoprostol NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Diclofenac Sodium and Misoprostol NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Diclofenac Sodium and Misoprostol	Diclofenac sodium 50 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	Amneal Pharmaceuticals LLC	65162-436	65162-0436-0365162-0436-0665162-0436-09+1 more
Diclofenac Sodium and Misoprostol	Diclofenac sodium 75 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	Amneal Pharmaceuticals LLC	65162-438	65162-0438-0365162-0438-0665162-0438-10
Diclofenac Sodium and Misoprostol	Diclofenac sodium 75 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	Bryant Ranch Prepack	71335-1183	71335-1183-0171335-1183-0271335-1183-03+2 more
Diclofenac Sodium and Misoprostol	Diclofenac sodium 50 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	BluePoint Laboratories	68001-231	68001-0231-06
Diclofenac Sodium and Misoprostol	Diclofenac sodium 75 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	BluePoint Laboratories	68001-232	68001-0232-06
Diclofenac Sodium and Misoprostol	Diclofenac sodium 50 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	AvKARE	42291-232	42291-0232-60
Diclofenac Sodium and Misoprostol	Diclofenac sodium 75 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	AvKARE	42291-233	42291-0233-60
Diclofenac Sodium and Misoprostol	Diclofenac sodium 50 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	Actavis Pharma, Inc.	0591-0397	00591-0397-1900591-0397-60
Diclofenac sodium and Misoprostol	Diclofenac sodium 50 mg/1; Misoprostol 200 ug/1	Tablet, Film coatedOral	Mylan Pharmaceuticals Inc.	59762-0028	59762-0028-0159762-0028-02
Diclofenac sodium and Misoprostol	Diclofenac sodium 75 mg/1; Misoprostol 200 ug/1	Tablet, Film coatedOral	Mylan Pharmaceuticals Inc.	59762-0029	59762-0029-01

Other NDCs under ANDA 201089

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201089
Product	Strength	Form · route	Labeler	Product NDC
Diclofenac Sodium and Misoprostol	Diclofenac sodium 50 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	Actavis Pharma, Inc.	0591-0397
Diclofenac Sodium and Misoprostol	Diclofenac sodium 50 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	AvKARE	42291-232
Diclofenac Sodium and Misoprostol	Diclofenac sodium 75 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	AvKARE	42291-233
Diclofenac Sodium and Misoprostol	Diclofenac sodium 50 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	BluePoint Laboratories	68001-231
Diclofenac Sodium and Misoprostol	Diclofenac sodium 75 mg/1; Misoprostol 200 ug/1	Tablet, Delayed releaseOral	BluePoint Laboratories	68001-232